|
|
|
Volumn 27, Issue 3, 2013, Pages 164-
|
|
FDA approves regorafenib (Stivarga) for GIST.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBANILAMIDE DERIVATIVE;
PYRIDINE DERIVATIVE;
REGORAFENIB;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TUMOR;
HUMAN;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
PHENYLUREA COMPOUNDS;
PYRIDINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84879327897
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|